The institution wants to raise another $1 billion by 2020.
BY JACOB PALMER | DIGITAL NEWS EDITOR
Oregon Health & Science University wants to raise another $1 billion by 2020.
The institution touted strides made in finding a vaccine to prevent the spread of HIV.
The team soon will be seeking volunteers to take part in a preparatory study ahead of clinical vaccine trials, which are expected to start in late 2016 or early 2017. If all goes well, a vaccine will be generally available in a decade.
“Two things can stop it,” [Dr. Belinda] Beresford said. “The first is if it doesn’t work as planned and the second is money. Human clinical trials are expensive… If they don’t have the money, the vaccine will sit in a freezer and the trials won’t happen.”
(SOURCE: Portland Business Journal)
In addition to ending the spread of HIV/AIDS, OHSU identified preventable blindness, heart disease and brain disease as “research goals.”